New Insights into the Hendra Virus Attachment and Entry Process from Structures of the Virus G Glycoprotein and Its Complex with Ephrin-B2

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Xu, Kai ^a   Chan, Yee Peng ^b   Rajashankar, Kanagalaghatta R ^c   Khetawat, Dimple ^b   Yan, Lianying ^b   Kolev, Momchil V ^a   Broder, Christopher C ^b   Nikolov, Dimitar B ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c ARGONNE NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPHRIN B2; EPHRIN B3; G GLYCOPROTEIN; TRYPTOPHAN; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CRYSTAL STRUCTURE; HENDRA VIRUS; MUTAGENESIS; NONHUMAN; PROTEIN DOMAIN; RECEPTOR BINDING; VIRUS ATTACHMENT; VIRUS ENTRY;

CRYSTALLOGRAPHY, X-RAY; EPHRIN-B2; GLYCOPROTEINS; HEK293 CELLS; HELA CELLS; HENDRA VIRUS; HUMANS; MODELS, BIOLOGICAL; MUTAGENESIS, SITE-DIRECTED; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, VIRUS; VIRAL PROTEINS; VIRUS ATTACHMENT; VIRUS INTERNALIZATION;

HENDRA VIRUS; HENIPAVIRUS; NIPAH VIRUS;

EID: 84868358785     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048742     Document Type: Article

References (60)

1. Eaton BT, Mackenzie JS, Wang LF (2007) Henipaviruses. In: Knipe DM, Howley PM, editors. Fields Virology. 5 ed. Philadelphia: Lippincott Williams & Wilkins. pp. 1587-1600.
2. Broder CC, (2012) Henipavirus outbreaks to antivirals: the current status of potential therapeutics. Curr Opin Virol 2: 176-187.
3. Anonymous (2012) Hendra virus, equine- Australia (10): Queensland. International Society for Infectious Diseases 20120907.1284588 20120907.1284588.
4. Bishop KA, Broder CC (2008) Hendra and Nipah: Lethal Zoonotic Paramyxoviruses. In: Scheld WM, Hammer SM, Hughes JM, editors. Emerging Infections. Washington, D.C.: American Society for Microbiology. pp. 155-187.
5. Playford EG, McCall B, Smith G, Slinko V, Allen G, et al. (2010) Human Hendra virus encephalitis associated with equine outbreak, Australia, 2008. Emerg Infect Dis 16: 219-223.
6. Anonymous (2009) Hendra virus, human, equine- Australia (05): Queensland. International Society for Infectious Diseases. 20090910.3189 20090910.3189.
7. Anonymous (2010) Hendra virus, equine- Australia (03): (QL) human exp. International Society for Infectious Diseases. 20100522.1699 20100522.1699.
8. Bossart KN, Zhu Z, Middleton D, Klippel J, Crameri G, et al. (2009) A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infection. PLoS Pathog 5: e1000642.
9. Geisbert TW, Daddario-DiCaprio KM, Hickey AC, Smith MA, Chan YP, et al. (2010) Development of an acute and highly pathogenic nonhuman primate model of Nipah virus infection. PLoS One 5: e10690.
10. Rockx B, Bossart KN, Feldmann F, Geisbert JB, Hickey AC, et al. (2010) A novel model of lethal Hendra virus infection in African green monkeys and the effectiveness of ribavirin treatment. J Virol 84: 9831-9839.
11. Eaton BT, Broder CC, Middleton D, Wang LF, (2006) Hendra and Nipah viruses: different and dangerous. Nat Rev Microbiol 4: 23-35.
12. Skehel JJ, Wiley DC, (2000) Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 69: 531-569.
13. Lamb RA, Parks GD (2007) Paramyxoviridae: The Viruses and Their Replication. In: Knipe DM, Howley PM, editors. Fields Virology. 5 ed. Philadelphia: Lippincott Williams & Wilkins. pp. 1449-1496.
14. Dutch RE, (2010) Entry and Fusion of Emerging Paramyxoviruses. PLoS Pathog 6: e1000881.
15. Bossart KN, Broder CC (2009) Paramyxovirus Entry. In: Pöhlmann S, Simmons G, editors. Viral Entry into Host Cells. Austin, TX Landes Bioscience.
16. Bossart KN, Crameri G, Dimitrov AS, Mungall BA, Feng YR, et al. (2005) Receptor binding, fusion inhibition, and induction of cross-reactive neutralizing antibodies by a soluble G glycoprotein of Hendra virus. J Virol 79: 6690-6702.
17. Negrete OA, Levroney EL, Aguilar HC, Bertolotti-Ciarlet A, Nazarian R, et al. (2005) EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus. Nature 436: 401-405.
18. Bonaparte MI, Dimitrov AS, Bossart KN, Crameri G, Mungall BA, et al. (2005) Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus. Proc Natl Acad Sci U S A 102: 10652-10657.
19. Bishop KA, Stantchev TS, Hickey AC, Khetawat D, Bossart KN, et al. (2007) Identification of Hendra virus G glycoprotein residues that are critical for receptor binding. J Virol 81: 5893-5901.
20. Negrete OA, Wolf MC, Aguilar HC, Enterlein S, Wang W, et al. (2006) Two key residues in ephrinB3 are critical for its use as an alternative receptor for Nipah virus. PLoS Pathog 2: e7.
21. Smith EC, Popa A, Chang A, Masante C, Dutch RE, (2009) Viral entry mechanisms: the increasing diversity of paramyxovirus entry. FEBS J 276: 7217-7227.
22. Lee JK, Prussia A, Paal T, White LK, Snyder JP, et al. (2008) Functional interaction between paramyxovirus fusion and attachment proteins. J Biol Chem 283: 16561-16572.
23. Paal T, Brindley MA, St Clair C, Prussia A, Gaus D, et al. (2009) Probing the spatial organization of measles virus fusion complexes. J Virol 83: 10480-10493.
24. Bishop KA, Hickey AC, Khetawat D, Patch JR, Bossart KN, et al. (2008) Residues in the stalk domain of the hendra virus g glycoprotein modulate conformational changes associated with receptor binding. J Virol 82: 11398-11409.
25. Deng R, Wang Z, Mirza AM, Iorio RM, (1995) Localization of a domain on the paramyxovirus attachment protein required for the promotion of cellular fusion by its homologous fusion protein spike. Virology 209: 457-469.
26. Melanson VR, Iorio RM, (2006) Addition of N-glycans in the stalk of the Newcastle disease virus HN protein blocks its interaction with the F protein and prevents fusion. J Virol 80: 623-633.
27. Stone-Hulslander J, Morrison TG, (1997) Detection of an interaction between the HN and F proteins in Newcastle disease virus-infected cells. J Virol 71: 6287-6295.
28. Stone-Hulslander J, Morrison TG, (1999) Mutational analysis of heptad repeats in the membrane-proximal region of Newcastle disease virus HN protein. J Virol 73: 3630-3637.
29. Takimoto T, Taylor GL, Connaris HC, Crennell SJ, Portner A, (2002) Role of the hemagglutinin-neuraminidase protein in the mechanism of paramyxovirus-cell membrane fusion. J Virol 76: 13028-13033.
30. Tanabayashi K, Compans RW, (1996) Functional interaction of paramyxovirus glycoproteins: identification of a domain in Sendai virus HN which promotes cell fusion. J Virol 70: 6112-6118.
31. Tsurudome M, Kawano M, Yuasa T, Tabata N, Nishio M, et al. (1995) Identification of regions on the hemagglutinin-neuraminidase protein of human parainfluenza virus type 2 important for promoting cell fusion. Virology 213: 190-203.
32. Bowden TA, Aricescu AR, Gilbert RJ, Grimes JM, Jones EY, et al. (2008) Structural basis of Nipah and Hendra virus attachment to their cell-surface receptor ephrin-B2. Nat Struct Mol Biol 15: 567-572.
33. Bowden TA, Crispin M, Harvey DJ, Jones EY, Stuart DI, (2010) Dimeric architecture of the Hendra virus attachment glycoprotein: evidence for a conserved mode of assembly. J Virol 84: 6208-6217.
34. Colgrave ML, Snelling HJ, Shiell BJ, Feng YR, Chan YP, et al. (2012) Site occupancy and glycan compositional analysis of two soluble recombinant forms of the attachment glycoprotein of Hendra virus. Glycobiology 22: 572-584.
35. Crennell S, Takimoto T, Portner A, Taylor G, (2000) Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase. Nat Struct Biol 7: 1068-1074.
36. Ryan C, Zaitsev V, Tindal DJ, Dyason JC, Thomson RJ, et al. (2006) Structural analysis of a designed inhibitor complexed with the hemagglutinin-neuraminidase of Newcastle disease virus. Glycoconj J 23: 135-141.
37. Yuan P, Thompson TB, Wurzburg BA, Paterson RG, Lamb RA, et al. (2005) Structural studies of the parainfluenza virus 5 hemagglutinin-neuraminidase tetramer in complex with its receptor, sialyllactose. Structure 13: 803-815.
38. Colf LA, Juo ZS, Garcia KC, (2007) Structure of the measles virus hemagglutinin. Nat Struct Mol Biol 14: 1227-1228.
39. Hashiguchi T, Kajikawa M, Maita N, Takeda M, Kuroki K, et al. (2007) Crystal structure of measles virus hemagglutinin provides insight into effective vaccines. Proc Natl Acad Sci U S A.
40. Yuan P, Swanson KA, Leser GP, Paterson RG, Lamb RA, et al. (2011) Structure of the Newcastle disease virus hemagglutinin-neuraminidase (HN) ectodomain reveals a four-helix bundle stalk. Proc Natl Acad Sci U S A 108: 14920-14925.
41. Brindley MA, Plemper RK (2010) Blue Native-PAGE and Biomolecular Complementation Reveal a Tetrameric or Higher Order Oligomer Organization of the Physiological Measles Virus Attachment (H) Protein. J Virol.
42. Zaitsev V, von Itzstein M, Groves D, Kiefel M, Takimoto T, et al. (2004) Second sialic acid binding site in Newcastle disease virus hemagglutinin-neuraminidase: implications for fusion. J Virol 78: 3733-3741.
43. Yuan P, Leser GP, Demeler B, Lamb RA, Jardetzky TS, (2008) Domain architecture and oligomerization properties of the paramyxovirus PIV 5 hemagglutinin-neuraminidase (HN) protein. Virology 378: 282-291.
44. Toth J, Cutforth T, Gelinas AD, Bethoney KA, Bard J, et al. (2001) Crystal structure of an ephrin ectodomain. Dev Cell 1: 83-92.
45. Himanen JP, Rajashankar KR, Lackmann M, Cowan CA, Henkemeyer M, et al. (2001) Crystal structure of an Eph receptor-ephrin complex. Nature 414: 933-938.
46. Bossart KN, McEachern JA, Hickey AC, Choudhry V, Dimitrov DS, et al. (2007) Neutralization assays for differential henipavirus serology using Bio-Plex protein array systems. J Virol Methods 142: 29-40.
47. Lee B, Ataman ZA, (2011) Modes of paramyxovirus fusion: a Henipavirus perspective. Trends Microbiol 19: 389-399.
48. Connolly SA, Leser GP, Jardetzky TS, Lamb RA, (2009) Bimolecular complementation of paramyxovirus fusion and hemagglutinin-neuraminidase proteins enhances fusion: implications for the mechanism of fusion triggering. J Virol 83: 10857-10868.
49. Chan YP, Lu M, Dutta S, Yan L, Barr J, et al. (2012) Biochemical, conformational, and immunogenic analysis of soluble trimeric forms of henipavirus fusion glycoproteins. J Virol 86: 11457-11471.
50. Xu K, Rajashankar KR, Chan YP, Himanen JP, Broder CC, et al. (2008) Host cell recognition by the henipaviruses: Crystal structures of the Nipah G attachment glycoprotein and its complex with ephrin-B3. Proc Natl Acad Sci U S A.
51. Khetawat D, Broder CC, (2010) A functional henipavirus envelope glycoprotein pseudotyped lentivirus assay system. Virol J 7: 312.
52. Negrete OA, Chu D, Aguilar HC, Lee B, (2007) Single amino acid changes in the Nipah and Hendra virus attachment glycoproteins distinguish ephrinB2 from ephrinB3 usage. J Virol 81: 10804-10814.
53. Chrencik JE, Brooun A, Recht MI, Kraus ML, Koolpe M, et al. (2006) Structure and thermodynamic characterization of the EphB4/Ephrin-B2 antagonist peptide complex reveals the determinants for receptor specificity. Structure 14: 321-330.
54. Otwinowski Z, Minor W, (1997) Processing of X-ray Diffraction Data Collected in Oscillation Mode. Methods in Enzymology, CW Carter, Jr & R M Sweet, Eds, Academic Press (New York) 276: 307-326.
55. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, et al. (2007) Phaser crystallographic software. J Appl Crystallogr 40: 658-674.
56. Terwilliger TC, Grosse-Kunstleve RW, Afonine PV, Moriarty NW, Zwart PH, et al. (2008) Iterative model building, structure refinement and density modification with the PHENIX AutoBuild wizard. Acta Crystallogr D Biol Crystallogr 64: 61-69.
57. Jones TA, Zou JY, Cowan SW, Kjeldgaard M, (1991) Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A 47 (Pt 2): 110-119.
58. DeLano WL (2002) The PyMOL Molecular Graphics System. (DeLano Scientific LLC, San Carlos, CA).
59. Niwa H, Yamamura K, Miyazaki J, (1991) Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108: 193-199.
60. Connor RI, Chen BK, Choe S, Landau NR, (1995) Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 206: 935-944.